Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02024087
Title Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Acceleron Pharma, Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.